POM-V Prescription Required Companion Animal

Apovomin 3 mg/ml Solution for Injection for Dogs

Active ingredient: Apomorphine Hydrochloride

Form

Injection

Species

Dogs

Manufacturer

Dechra Regulatory B.V.

VMD MA No.

50406/4002

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Apomorphine Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Apovomin 3 mg/ml Solution for Injection for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For single subcutaneous administration only.
0.05-0.1 mg of apomorphine hydrochloride hemihydrate per kg bodyweight
(approximately 0.02-0.03 ml veterinary medicinal product per kg bodyweight).
An appropriately graduated syringe must be used to allow accurate administration of
the required dose volume. This is particularly important when injecting small volumes.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
Do not use if the solution has turned green.

Do not use in cats.
Do not use in case of depression of the Central Nervous System (CNS).
Do not use in cases of ingestion of caustic agents (acids or alkalis), foamy products,
volatile substances, organic solvents and non-blunt objects (e.g. glass).
AN: 03269/2024 & 03271/2024
Do not use in animals which are hypoxic, dyspnoeic, seizuring, in hyperexcitation,
extremely weak, ataxic, comatose, lacking normal pharyngeal reflexes, or suffering
other marked neurologic impairments that could lead to aspiration pneumonia.
Do not use in cases of circulatory failure, shock and anaesthesia.
Do not use in animals which are previously treated with Dopamine-Antagonists
(Neuroleptics).
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.

Dogs:
Very common
(>1 animal / 10 animals
treated):
Drowsiness
a
; Decreased appetite
a
;
Hypersalivation
a
;
Immediate pain upon injection
a, b
.
Common
(1 to 10 animals / 100 animals
treated):
Dehydration
a,

c
;
Tachycardia
a
, Bradycardia
a
.
Undetermined frequency
(cannot be estimated from the
available data)
Low blood pressure.
a
Transient and may be related to the physiological response to expulsive efforts.
b
Mild to moderate.
c
Slight.
Multiple episodes of vomiting may be observed, and vomiting may occur up to
several hours after the injection.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Expulsive efforts with or without vomiting are likely to be seen from 2 to 15 minutes
after the injection of the veterinary medicinal product and may last from 2 minutes to
2.5 hours. If emesis is not induced following a single injection, do not repeat the
injection as it will not be effective and may provoke clinical signs of toxicity.

Special precautions for safe use in the target species:
In dogs with known severe hepatic failure, the benefit-risk balance for use of the
veterinary medicinal product in such animals should be considered by the
veterinarian.
Before administering the veterinary medicinal product, consideration must be given to
the time of the ingestion of the substance (in relation to gastric emptying times) and
on the suitability of inducing emesis based the type of substance ingested (see also
section 3.3).
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This veterinary medicinal product may cause nausea and somnolence. In case of
accidental self–injection, seek medical advice immediately and show the package
leaflet or the label to the physician. DO NOT DRIVE, as sedation may occur.
Apomorphine has been shown to have teratogenic effects in laboratory animals and
is excreted in breast milk. Pregnant or breast-feeding women should avoid handling
the veterinary medicinal product.
This veterinary medicinal product may cause hypersensitivity reactions. People with
known hypersensitivity to apomorphine or any of the excipients should avoid contact
with the veterinary medical product.
If the veterinary medicinal product comes into contact with the skin or eyes, rinse
immediately with water. Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
AN: 03269/2024 & 03271/2024

Neuroleptics (e.g. chlorpromazine, haloperidol), and anti-emetics (metoclopramide,
domperidone) reduce or suppress the emesis induced by the administration of
apomorphine.
The administration or the prior ingestion of opiates or barbiturates can induce additive
CNS effects and respiratory depression with apomorphine.
AN: 03269/2024 & 03271/2024
Caution is advised when dogs are receiving other dopamine agonists, such as
cabergoline, due to possible additive effects such as exacerbation or inhibition of
vomiting.

5 ml and 10 ml vial: Store in a refrigerator (2°C to 8°C). Do not freeze.
20 ml vial: Do not freeze.

Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Your Rights

Prescription Fee Cap Can My Vet Refuse a Prescription? Buy Pet Medication Online

Same active ingredient

Other Products Containing Apomorphine Hydrochloride

These products share the same active ingredient and may be suitable alternatives. Always consult your vet.

Apovomin 1 mg/ml Solution for Injection for Dogs

POM-V

Dechra Regulatory B.V.

injection Dogs

Alternative options to consider

Retailers we earn a commission from. It costs you nothing and never changes what we show.

The Pharm Pet Co.

The Pharm Pet Co. — Pet Pharmacy

UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.

Save up to 50% Shop now

Pharmacy2U

Pet Care at Pharmacy2U

The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.

Free delivery £30+ Shop now

VetBox

VetBox Flea & Worm Protection for Dogs

Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.

From £9.99/month Shop now

We may earn a small commission if you purchase through these links, at no extra cost to you.

Also in gastrointestinal